Literature DB >> 3271554

Structural studies of analgesics and their interactions. XII. Structure and interactions of anti-inflammatory fenamates. A concerted crystallographic and theoretical conformational study.

V Dhanaraj1, M Vijayan.   

Abstract

A theoretical conformational analysis of fenamates, which are N-arylated derivatives of anthranilic acid or 2-aminonicotinic acid with different substituents on the aryl (phenyl) group, is reported. The analysis of these analgesics, which are believed to act through the inhibition of prostaglandin biosynthesis, was carried out using semi-empirical potential functions. The results and available crystallographic observations have been critically examined in terms of their relevance to drug action. Crystallographic studies of these drugs and their complexes have revealed that the fenamate molecules share a striking invariant feature, namely, the six-membered ring bearing the carboxyl group is coplanar with the carboxyl group and the bridging imino group, the coplanarity being stabilized by resonance interactions and an internal hydrogen bond between the imino and carboxyl groups. The results of the theoretical analysis provide a conformational rationale for the observed invariant coplanarity. The second six-membered ring, which provides hydrophobicity in a substantial part of the molecule, has limited conformational flexibility in meclofenamic, mefenamic and flufenamic acids. Comparison of the conformational energy maps of these acids shows that they could all assume the same conformation when bound to the relevant enzyme. The present study provides a structural explanation for the difference in the activity of niflumic acid, which can assume a conformation in which the whole molecule is nearly planar. The main role of the carboxyl group appears to be to provide a site for intermolecular interactions in addition to helping in stabilizing the invariant coplanar feature and providing hydrophilicity at one end of the molecule. The fenamates thus provide a good example of conformation-dependent molecular asymmetry.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3271554     DOI: 10.1107/s0108768188001107

Source DB:  PubMed          Journal:  Acta Crystallogr B        ISSN: 0108-7681


  9 in total

1.  The structural and electronical factors that contribute affinity for the time-dependent inhibition of PGHS-1 by indomethacin, diclofenac and fenamates.

Authors:  R Pouplana; C Pérez; J Sánchez; J J Lozano; P Puig-Parellada
Journal:  J Comput Aided Mol Des       Date:  1999-05       Impact factor: 3.686

2.  Additive-induced metastable single crystal of mefenamic acid.

Authors:  Eun Hee Lee; Stephen R Byrn; M Teresa Carvajal
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

3.  Nonamorphism in flufenamic acid and a new record for a polymorphic compound with solved structures.

Authors:  Vilmalí López-Mejías; Jeff W Kampf; Adam J Matzger
Journal:  J Am Chem Soc       Date:  2012-06-12       Impact factor: 15.419

4.  Quantum Chemical Study on Mefenamic Acid Polymorphic Forms.

Authors:  Svitlana V Shishkina; Yevhenii A Vaksler; Irina S Konovalova; Victoriya V Dyakonenko; Victoriya V Varchenko
Journal:  ACS Omega       Date:  2022-05-16

5.  Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.

Authors:  Antonella Liantonio; Alessandra Picollo; Giuseppe Carbonara; Giuseppe Fracchiolla; Paolo Tortorella; Fulvio Loiodice; Antonio Laghezza; Elena Babini; Giovanni Zifarelli; Michael Pusch; Diana Conte Camerino
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-23       Impact factor: 11.205

6.  Characterization of the interaction between fenamates and hippocampal neuron GABA(A) receptors.

Authors:  Leanne Coyne; Jiping Su; Debra Patten; Robert F Halliwell
Journal:  Neurochem Int       Date:  2007-05-03       Impact factor: 3.921

7.  Potentiation of large conductance KCa channels by niflumic, flufenamic, and mefenamic acids.

Authors:  M Ottolia; L Toro
Journal:  Biophys J       Date:  1994-12       Impact factor: 4.033

8.  Structure-activity relationship of fenamates as Slo2.1 channel activators.

Authors:  Priyanka Garg; Michael C Sanguinetti
Journal:  Mol Pharmacol       Date:  2012-07-31       Impact factor: 4.436

9.  Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation.

Authors:  Nasir Abbas; Iain D H Oswald; Colin R Pulham
Journal:  Pharmaceutics       Date:  2017-05-16       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.